NO932057D0 - Ny menneske-dopamin-reseptor og dens anvendelser - Google Patents

Ny menneske-dopamin-reseptor og dens anvendelser

Info

Publication number
NO932057D0
NO932057D0 NO932057A NO932057A NO932057D0 NO 932057 D0 NO932057 D0 NO 932057D0 NO 932057 A NO932057 A NO 932057A NO 932057 A NO932057 A NO 932057A NO 932057 D0 NO932057 D0 NO 932057D0
Authority
NO
Norway
Prior art keywords
dopamine receptor
human
applications
new human
receptor
Prior art date
Application number
NO932057A
Other languages
English (en)
Other versions
NO932057L (no
NO311363B1 (no
Inventor
Olivier Civelli
Hubert Van Tol
Original Assignee
Oregon Board Of H Education Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Board Of H Education Of filed Critical Oregon Board Of H Education Of
Publication of NO932057D0 publication Critical patent/NO932057D0/no
Publication of NO932057L publication Critical patent/NO932057L/no
Publication of NO311363B1 publication Critical patent/NO311363B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/9413—Dopamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
NO19932057A 1990-12-07 1993-06-04 DNA-sekvens som koder for en dopamin-menneske-reseptor-D4, homogen sammensetning inneholdende reseptoren, anvendelse avnukleotidsekvensen, samt ekspresjonsvektor og cellekulturomfattende nukleotidsekvensen og anvendelse av ekspresjonsve NO311363B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,618 US5422265A (en) 1990-12-07 1990-12-07 DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells
PCT/US1991/009308 WO1992010571A1 (en) 1990-12-07 1991-12-06 Human dopamine d4 receptor and its uses

Publications (3)

Publication Number Publication Date
NO932057D0 true NO932057D0 (no) 1993-06-04
NO932057L NO932057L (no) 1993-08-09
NO311363B1 NO311363B1 (no) 2001-11-19

Family

ID=24511138

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19932057A NO311363B1 (no) 1990-12-07 1993-06-04 DNA-sekvens som koder for en dopamin-menneske-reseptor-D4, homogen sammensetning inneholdende reseptoren, anvendelse avnukleotidsekvensen, samt ekspresjonsvektor og cellekulturomfattende nukleotidsekvensen og anvendelse av ekspresjonsve

Country Status (11)

Country Link
US (2) US5422265A (no)
EP (1) EP0574406B1 (no)
JP (1) JP2966093B2 (no)
AT (1) ATE196925T1 (no)
AU (1) AU652211B2 (no)
CA (1) CA2097698C (no)
DE (1) DE69132447T2 (no)
DK (1) DK0574406T3 (no)
FI (1) FI932573A (no)
NO (1) NO311363B1 (no)
WO (1) WO1992010571A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277591B1 (en) 1988-11-18 2001-08-21 Oregon Health Science University Dopamine receptors and genes
US5569601A (en) * 1990-12-07 1996-10-29 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Human dopamine receptor and its uses
JP2718827B2 (ja) * 1991-10-16 1998-02-25 カイロン コーポレーション 分泌Ｍａｃ−２結合糖タンパク質
US5766948A (en) * 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6486310B1 (en) * 1993-01-28 2002-11-26 Washington University Gene encoding the rat dopamine D4 receptor
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5622950A (en) * 1993-03-01 1997-04-22 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
PL310443A1 (en) * 1993-03-01 1995-12-11 Merck Sharp & Dohme Derivatives of pyrolo-pyridine
US5468615A (en) * 1993-07-01 1995-11-21 The Upjohn Company Binding assay employing a synthetic gene for D4 dopamine receptors
CA2172547A1 (en) * 1993-09-28 1995-04-06 Joshua Owolabi Expression of human d4 dopamine receptors in stable cell lines
US5994503A (en) * 1995-03-27 1999-11-30 Yale University Nucleotide and protein sequences of lats genes and methods based thereon
US6531314B1 (en) * 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
WO1997046680A1 (en) * 1996-06-05 1997-12-11 Chiron Corporation Dna encoding dp. 75 and a process for its use
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
JP2002522058A (ja) 1998-08-10 2002-07-23 メルク・アンド・カンパニー・インコーポレーテッド イヌ成長ホルモン分泌促進物質受容体
US6783973B1 (en) 2000-09-12 2004-08-31 Oregon Health & Science University Mammalian catecholamine receptor genes and uses
US7381542B2 (en) * 2001-07-09 2008-06-03 Oregon Health & Science University Nucleic acids encoding a biogenic amine receptor
CA2607095A1 (en) * 2005-05-05 2006-11-09 Centre For Addiction And Mental Health Compositions and methods for modulating dopamine neurotransmission
CA2727086C (en) * 2008-06-12 2018-01-02 Centre For Addiction And Mental Health Compositions and methods for modulating d1-d2 dopamine receptor interaction and function

Also Published As

Publication number Publication date
ATE196925T1 (de) 2000-10-15
EP0574406B1 (en) 2000-10-11
EP0574406A1 (en) 1993-12-22
JP2966093B2 (ja) 1999-10-25
AU9140391A (en) 1992-07-08
DE69132447T2 (de) 2001-03-08
WO1992010571A1 (en) 1992-06-25
AU652211B2 (en) 1994-08-18
NO932057L (no) 1993-08-09
DK0574406T3 (da) 2000-11-13
DE69132447D1 (de) 2000-11-16
FI932573A0 (fi) 1993-06-04
CA2097698A1 (en) 1992-06-08
US5594108A (en) 1997-01-14
US5422265A (en) 1995-06-06
CA2097698C (en) 1999-06-01
FI932573A (fi) 1993-07-09
JPH06503958A (ja) 1994-05-12
NO311363B1 (no) 2001-11-19

Similar Documents

Publication Publication Date Title
NO932057L (no) Ny dopamin-menneske-reseptor og dens anvendelser
WO1994003602A3 (en) A novel human dopamine receptor and its uses
NO943775D0 (no) Melanocyt stimulerende hormon reseptor og anvendelse derav
BR9813608A (pt) Polipeptìdeo isolado, sequências de ácido nucleico isolado e mutante, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, processos para produzir uma sequência de ácido nucleico mutante, para produzir um polipeptìdeo, para produzir um mutante de uma célula originária e para produzir uma proteìna, e, célula mutante
DK0977874T3 (da) Svækket salmonella-stamme anvendt som bæremedium til oral immunisering
ES2118066T3 (es) Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
ES8202588A1 (es) Un procedimiento para la preparacion de una proteina quimera
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
WO2021000969A3 (zh) 表达SARS-CoV-2病毒抗原肽的核酸序列及其应用
DE3750125D1 (de) Biologische eindämmung.
DK0856581T3 (da) Stabilt transficerede cellelinjer, der udtrykker GABA-A-receptorer
DK0843731T3 (da) Adenovirusvektorer til genterapi
IL90334A0 (en) Genetic transformation of b.thuringiensis,vectors used therefor,host cells transformed by the vectors and use of said cells as insecticides
MEP37808A (en) Dna encoding a novel rg1 polypeptide
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
AU1242188A (en) Isolation of single chain proteins with fsh suppressing activity from follicular fluid
GB9919409D0 (en) Baculovirus expression system
HUP9801438A2 (hu) Növényekben előállított rekombináns preduodenális lipázok és polipeptid-származékaik, előállításuk és alkalmazásuk
DK1196560T3 (da) Neurotrofisk faktor receptor GFR-alfa-4
HU9500619D0 (en) Cloning and expression of b-app-c100 receptor
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
DE69637628D1 (de) Episomaler vektor und dessen verwendung
HUP0104598A1 (hu) Hepatocita-eredetű növekedési faktorból (HGF) és makrofágstimuláló proteinből (MSP) származó rekombináns proteinek
DK336887A (da) Enzymer